New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival

Surgery. 1983 Mar;93(3):357-64.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Ascites / drug therapy
  • Ascites / etiology
  • Ascites / immunology*
  • Biological Products / therapeutic use*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Intestinal Neoplasms / complications
  • Intestinal Neoplasms / immunology*
  • Intestinal Neoplasms / mortality
  • Intestine, Large
  • Leukocyte Count
  • Male
  • Middle Aged
  • Palliative Care
  • Picibanil / adverse effects
  • Picibanil / therapeutic use*
  • Prognosis
  • Skin Tests
  • Stomach Neoplasms / complications
  • Stomach Neoplasms / immunology*
  • Stomach Neoplasms / mortality
  • T-Lymphocytes / immunology

Substances

  • Biological Products
  • Picibanil